$Recursion Pharmaceuticals(RXRX.US) If, and I mean if, if the market completes its bottoming out because of this earnings report, then a possible narrative path could be: the fear that "this company might go under, and run out of money before achieving results" is dispelled or alleviated by "cost control." Then the market's possible interpretation narrative might become: is there a chance things will get better tomorrow? One thing is for sure, this is a high-beta investment similar to a primary market investment;